Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
The position for induction chemotherapy has shifted somewhat in the past few years. This approach has the ability to reduce distant failure and is relatively easy to administer. There are patients who would benefit from and could be offered induction chemotherapy--specifically, those who would not tolerate concurrent chemoradiotherapy or those who might benefit from more intensive therapy combing induction and concurrent strategies. The latter platform, however, should be undertaken with caution, ideally in a clinical trial setting.
Section of Hematology/Oncology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Room MC2115, Chicago, IL 60637-1470, USA. ecohen@medicine.bsd.uchicago.edu
Ezra E W
EE
Cohen
Everett E
EE
Vokes
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011300:Preoperative Care; D011878:Radiotherapy / Q000379:methods